Autologous alpha-2-macroglobulin concentrate injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous alpha-2-macroglobulin concentrate injection, covering 2017-10-12 to 2017-10-12. Get the full timeline:
Most recent: Clinical Trial Update: Injection of an Autologous A2M Concentrate Alleviates Back Pain in FAC-positive Patients